Rezultati pretraživanja
  1. prije 1 sat

    You can find our CEO next week presenting our next-generation cell-therapy in NYC. &Families Cytonus Therapeutics Selected to Present at BIO CEO & Investor Conference in New York City via

  2. Excited to share new real-world data on the use of immunotherapy with oral agents in men with advanced prostate cancer at .

  3. prije 6 sati

    With funding from Gilead Sciences, Cardinal Health, Canaan Partners, and others, Vineti is planning to channel its software into making safer and more accessible for patients.

  4. prije 6 sati

    Did you know there are more than 400 active and recruiting clinical trials in and across the U.S.? You can search them using our Clinical Trials Finder, which is updated daily.

  5. prije 6 sati

    Listen to Nkarta Therapeutics' CSO James Trager talk about the company's platform on February 18, 2020.

  6. prije 7 sati

    Breaking News: Study in shows that CAR-NK induced high response rates among patients with relapsed/refractory non-Hodgkin lymphoma & chronic lymphocytic leukemia. Study led by Katy Rezvani, MD, PhD

  7. prije 7 sati

    CD19 NK- achieves 73% response rate in patients with leukemia and lymphoma

  8. prije 7 sati

    “I can breathe again. This is the beginning of my new life,” says Lynnette Williams-Briggs, 60, the first patient in Delaware to receive .

  9. prije 8 sati

    Great lecture by Dr. Clive Svendsen to our Master Program course SCRM 515: Bring Stem Cells to the Clinics. He walked through his journey of developing gene therapy for Parkinson's Disease and cell and gene therapy for ALS. Great work!

  10. Dr. Sowmya Viswanathan's is coming up on Feb. 20th! If you're interested in learning how to navigate the New Substance Notification Regulations for Organisms, register at our website:

  11. prije 10 sati

    There will be a time when you just have to take a deep breath, relax, and let things go. Focus on what and who really matters to you and the rest will work itself out... I Am S.C. Yatta Follow me on Facebook Instagram and Twitter @ S.C. Yatta

  12. prije 10 sati

    A big week! Vineti announced the close of our round of $35 million which will support our continued expansion in and , providing a global solution to industrialize in clinical through to commercial stage.

  13. prije 11 sati

    Gene Circuits Empower Next-Generation Cell and Gene Therapies: Senti Biosciences describes how “living drugs” may be programmed to fulfill user-defined functions

  14. Intense 1 day workshop on paying for + March 10th at MIT. This is targeted for , , and .

  15. prije 11 sati

    We are proud to accept the SelectScience Scientists' Choice Award for Drug Discovery & Development eBook of the Year 2019 for our eBook "Development of Antibody-Based Cancer Therapeutics" Read on:

  16. prije 11 sati

    Always a pleasure to collaborate with CERT to expand knowledge about The Business of Regenerative Medicine

  17. prije 12 sati

    welcomes the ARM initiative to promote advanced therapies. Many patients in various indications suffer from unmet medical need. Advanced therapies such as biological must be available to everyone in need.

  18. Gene Circuits Empower Next-Generation Cell and Gene Therapies: Senti Biosciences describes how “living drugs” may be programmed to fulfill user-defined functions

  19. FDA clears IND application for natural killer cell therapy for glioblastoma multiforme.

  20. Banking stem cells is acquiring and storing your stem cells in a safe place so when you need them, they are ready for your withdrawal.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.